Is cannabis a useful adjunct in the treatment of symptoms of persons with multiple sclerosis? A formal trial of CBD and THC for the control of spasticity and other symptoms: assessing the clinical effects and the basic mechanisms.
Is cannabis a useful adjunct in the treatment of symptoms of persons with multiple sclerosis? A formal trial of CBD and THC for the control of spasticity and other symptoms: assessing the clinical effects and the basic mechanisms.
大麻是治疗多发性硬化症患者症状的有用辅助药物吗？
批准号：
418215
负责人：
Duquette Pierre
金额：
$54.64万
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2019
资助国家：
加拿大
项目状态：
已结题
起止时间：
2019-10-01 至 2024-10-01
中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Multiple sclerosis (MS) is a chronic disease that manifests as relapses and/or progression. Multiple disease-modifying treatments (DMTs) are available to control the disease process. Lesser progress has been achieved to treat the multiple symptoms that MS
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金
